Mikkel W Pedersen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 2

Top Topics

Mesenchymal Stem Cells

Transcription Factor

Cerebrospinal Fluid

Tyrosine Kinase

Top Venues

Science translational medicine

Symphogen A/S

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Symphogen A/S Nov 01 2018

Denmark

Vice President :: Antibody Discovery and Research

Symphogen (Denmark) Jan 20 2012 - Oct 30 2018

Denmark

Director :: Cancer Biology and Immunology

Publications

Barbara Lupo, Francesco Sassi, Marika Pinnelli, Francesco Galimi, Eugenia R Zanella, Valentina Vurchio, Giorgia Migliardi, Paolo Armando Gagliardi, Alberto Puliafito, Daria Manganaro, Paolo Luraghi, Michael Kragh, Mikkel W Pedersen, Ivan D Horak, Carla Boccaccio, Enzo Medico, Luca Primo, Daniel Nichol, Inmaculada Spiteri, Timon Heide, Alexandra Vatsiou, Trevor A Graham, Elena Élez, Guillem Argiles, Paolo G Nuciforo, Andrea Sottoriva, Rodrigo Dienstmann, Diego Pasini, Elena Grassi, Claudio Isella, Andrea Bertotti, Livio Trusolino
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype. Science translational medicine 12 (555) (2021)
Torben Gjetting, Monika Gad, Camilla Fröhlich, Trine Lindsted, Maria C Melander, Vikram K Bhatia, Michael M Grandal, Nikolaj Dietrich, Franziska Uhlenbrock, Gunther R Galler, Magnus Strandh, Johan Lantto, Thomas Bouquin, Ivan D Horak, Michael Kragh, Mikkel W Pedersen, Klaus Koefoed
Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform. mAbs 11 (4) (2019)